Advanced in Tetanus

Monjori Mitra

11, Dr. Biresh Guha Street, 
Kolkata, WB, IN 
Advanced in Tetanus
11, Dr. Biresh Guha Street, 
Kolkata, WB, IN 
OverviewLocationsClinical Research

Overview

Monjori Mitra practices in Kolkata, India. Mitra is rated as an Advanced expert by MediFind in the treatment of Tetanus. Their top areas of expertise are Hepatitis A, Tetanus, Chickenpox, and Diphtheria.

Their clinical research consists of co-authoring 47 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Tetanus.

Locations

11, Dr. Biresh Guha Street, Kolkata, WB 700029, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Prospective, Multicenter, Single-arm, Open-label, Interventional Phase IV Study to Evaluate the Safety and Efficacy of Idursulfase (r-DNA Origin) (Elaprase™) in Indian Pediatric and Adult Population With Hunter Syndrome (Mucopolysaccharidosis II)
A Prospective, Multicenter, Single-arm, Open-label, Interventional Phase IV Study to Evaluate the Safety and Efficacy of Idursulfase (r-DNA Origin) (Elaprase™) in Indian Pediatric and Adult Population With Hunter Syndrome (Mucopolysaccharidosis II)
Enrollment Status: Completed
Publish Date: January 23, 2025
Intervention Type: Biological
Study Drug: Elaprase
Study Phase: Phase 4
Infant Feeding Practice and Gut Comfort: a Multi-country, Cross-sectional Observational Study
Infant Feeding Practice and Gut Comfort: a Multi-country, Cross-sectional Observational Study
Enrollment Status: Completed
Publish Date: October 04, 2023
Intervention Type: Other
Immunogenicity and Safety Study of Two Different Formulations of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine, Rotarix in Healthy Infants
Immunogenicity and Safety Study of Two Different Formulations of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine, Rotarix in Healthy Infants
Enrollment Status: Completed
Publish Date: December 09, 2020
Intervention Type: Biological
Study Phase: Phase 3
View 2 Less Clinical Trials

47 Total Publications

An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participants.
An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participants.
Journal: Human vaccines & immunotherapeutics
Published: August 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mitra's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile